LBA
WST icon

Lowell Blake & Associates’s West Pharmaceutical WST Stock Holding History

Lowell Blake & Associates’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,553
Closed -$427K – 50
2020
Q3 		$427K Buy
1,553
+15
+1% +$3.97K 0.34% 39
2020
Q2 		$349K Hold
1,538
– – 0.33% 41
2020
Q1 		$234K Hold
1,538
– – 0.3% 45
2019
Q4 		$231K Buy
+1,538
New +$224K 0.26% 53

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Lowell Blake & Associates's WST Position: Q4 2020 in Review

Lowell Blake & Associates sold out of West Pharmaceutical (WST) in Q4 2020, closing a stake of 1,553 shares — an estimated $427K sold.

Lowell Blake & Associates first reported a position in WST in Q4 2019 and held it in 4 quarters. The position peaked at $427K in Q3 2020. 593 funds tracked by Wall St. Rank hold WST as of Q4 2020.

  • Lowell Blake & Associates reported no remaining West Pharmaceutical position as of Q4 2020 after selling out during the quarter.
  • Lowell Blake & Associates sold 1,553 West Pharmaceutical shares in Q4 2020, an estimated $427K.
  • Lowell Blake & Associates first reported a position in West Pharmaceutical in Q4 2019 and held it in 4 quarters.
  • Lowell Blake & Associates's West Pharmaceutical position peaked at $427K in Q3 2020.
  • 593 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2020.

Based on Lowell Blake & Associates's 13F filing for Q4 2020, filed 4 Feb 2021.